BRIEF published on 03/18/2025 at 15:08, 1 year 3 months ago Groupe hôtelier Dalata : UBS acquiert des participations importantes Instruments Financiers Groupe Hôtelier Dalata Structure De L'actionnariat Acquisition D'UBS Principales Participations
PRESS RELEASE published on 03/18/2025 at 15:03, 1 year 3 months ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* UBS Investment Bank & Wealth Management acquires 4.44% voting rights in Dalata Hotel Group PLC. Threshold of 3% crossed on 14-March-2025 Voting Rights Major Holdings Notification Dalata Hotel Group Plc Financial Instruments UBS Investment Bank
BRIEF published on 03/14/2025 at 18:07, 1 year 3 months ago Dalata Hotel Group PLC: Recent Securities Dealings Securities Dealings Irish Takeover Panel Dalata Hotel Group Employee Benefit Trust Transparency Disclosure
BRIEF published on 03/14/2025 at 18:07, 1 year 3 months ago Dalata Hotel Group PLC : Transactions récentes sur titres Groupe Hôtelier Dalata Opérations Sur Valeurs Mobilières Commission Irlandaise Des Acquisitions Fiducie De Prestations Aux Employés Divulgation De Transparence
PRESS RELEASE published on 03/14/2025 at 18:02, 1 year 3 months ago Form 8.1(c) - Dalata Hotel Group PLC: Dalata Hotel Group PLC discloses dealing under Rule 8.1(c) and (d)(i) of Irish Takeover Panel Act regarding relevant securities. Employee Benefit Trust purchases shares Shares Irish Takeover Panel Dalata Hotel Group Plc Employee Benefit Trust Rule 8.1(c)
BRIEF published on 03/11/2025 at 13:45, 1 year 3 months ago UBS Group AG Adjusts Holdings in Dalata Hotel Group Voting Rights Shareholding Financial Instruments Dalata Hotel Group UBS Group AG
BRIEF published on 03/11/2025 at 13:45, 1 year 3 months ago UBS Group AG ajuste ses participations dans le groupe hôtelier Dalata Actionnariat Droit De Vote Instruments Financiers Groupe UBS SA Groupe Hôtelier Dalata
PRESS RELEASE published on 03/11/2025 at 13:40, 1 year 3 months ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* UBS Investment Bank & Wealth Management discloses 4.45% combined voting rights in Dalata Hotel Group PLC as of 07/03/2025 Voting Rights Investment Notification Dalata Hotel Group Plc UBS
BRIEF published on 03/10/2025 at 17:54, 1 year 3 months ago Dalata Hotel Group: Notification of Major Holdings Voting Rights Corporate Governance Financial Instruments Goldman Sachs Dalata Hotel Group
BRIEF published on 03/10/2025 at 17:54, 1 year 3 months ago Groupe hôtelier Dalata : Notification de participations importantes Gouvernance D'Entreprise Droit De Vote Instruments Financiers Goldman Sachs Groupe Hôtelier Dalata
Published on 06/26/2026 at 14:05, 2 hours 38 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 43 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 43 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 3 hours 58 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 1 hour 13 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 1 hour 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 15:22, 1 hour 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 06/26/2026 at 07:00, 9 hours 43 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 43 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel